4/A

PRIMARY DOCUMENT

Company: Raphael Pharmaceutical Inc.
Filed: November 25, 2008
Period of Report: October 2, 2008
Accession Number: 0001165527-08-000735

View Document ↗ View on SEC.gov ↗